Aromatase inhibitors use and risk for cardiovascular disease in breast cancer patients: A population-based cohort study

Aromatase inhibitors use and risk for cardiovascular disease in breast cancer patients: A population-based cohort study

Background: Prior studies regarding use of Aromatase inhibitors (AIs) and risk for cardiovascular disease (CVD) have shown conflicting results. This retrospective cohort study aimed to investigate whether AIs use affects risk for CVD events in postmenopausal breast cancer survivors. Methods: Using a...

Full description

Bibliographic Details
Main Authors: Maria Sund, Miguel Garcia-Argibay, Hans Garmo, Johan Ahlgren, Anna-Karin Wennstig, Irma Fredriksson, Henrik Lindman, Antonis Valachis
Format: Article
Language:English
Published: Elsevier 2021-10-01
Series:Breast
Subjects:
Breast cancer
Aromatase inhibitors
Cardiovascular disease
Survivorship
Online Access:http://www.sciencedirect.com/science/article/pii/S0960977621004124

Internet

http://www.sciencedirect.com/science/article/pii/S0960977621004124

Similar Items